Foresight Global Investors’s AstraZeneca AZN Stock Holding History

Foresight Global Investors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.7M	Sell	145,297 -39	-0%	-$7.52K	18.6%	1
2025 Q4	$51M	Buy	145,336 +23,747	+20%	+$4.16M	24.01%	1
2025 Q3	$18.7M	Buy	+121,589	New	+$18.4M	11.08%	3
2024 Q1	–	Sell	-129,014	Closed	-$17.4M	–	42
2023 Q4	$17.4M	Sell	129,014 -4,851	-4%	-$631K	9.96%	2
2023 Q3	$18.1M	Buy	133,865 +6,992	+6%	+$955K	10.09%	1
2023 Q2	$18.2M	Sell	126,873 -16,560	-12%	-$2.44M	9.8%	1
2023 Q1	$19.9M	Buy	+143,433	New	+$19.3M	14.27%	2

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Foresight Global Investors's AZN Position: Q1 2026 in Review

Foresight Global Investors reduced its AstraZeneca (AZN) stake by 0.03% in Q1 2026, selling an estimated $7.52K and leaving 145,297 shares worth $28.7M. The position accounts for 18.6% of the portfolio, ranked #1.

Foresight Global Investors first reported a position in AZN in Q1 2023 and has held it in 7 quarters since. The position peaked at $51M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Foresight Global Investors held 145,297 shares of AstraZeneca worth $28.7M as of Q1 2026.
Foresight Global Investors sold 39 AstraZeneca shares in Q1 2026, an estimated $7.52K.
AstraZeneca made up 18.6% of Foresight Global Investors's portfolio in Q1 2026, its #1 holding.
Foresight Global Investors first reported a position in AstraZeneca in Q1 2023 and has held it in 7 quarters since.
Foresight Global Investors's AstraZeneca position peaked at $51M in Q4 2025.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Foresight Global Investors's 13F filing for Q1 2026, filed 13 May 2026.